Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06293989Phase 3Not yet recruiting
Phase 3, randomised, double-blind trial of diazepam in Peripheral vertigo (3 arms), sponsored by Université de Monastir. Primary endpoint: Visual Analogue Scale at 3 hours. Planned start May 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06293989.